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White spotting variant (Wv) mice are spontaneous mutants attributed to a point mutation in the c-Kit gene, which
reduces the tyrosine kinase activity to around 1% and affects the development of melanocytes, mast cells, and
germ cells. Homozygous mutant mice are sterile but can live nearly a normal life span. The female Wv mice have a
greatly reduced ovarian germ cell and follicle reserve at birth, and the remaining follicles are largely depleted soon
after the females reach reproductive stage at around 7 weeks of age. Consequently, ovarian epithelial tumors
develop in 100% of Wv females by 3 to 4 months of age. These tumors, called tubular adenomas, are benign but
can become invasive in older Wv mice.
We tested if additional geneticmutation(s) could convert the benign ovarian epithelial tumors tomalignant tumors by
crossing the Wv mutant into the Trp53 knockout background. Surprisingly, we found that global deletion of Trp53
suppressed the development of ovarian tubular adenomas in Wv mice. The ovaries of Wv/Wv; Trp53 (−/−) mice
were covered by a single layer of surface epithelium and lacked excessive epithelial proliferation. Rather, the ovaries
contained a small number of follicles. The presence of ovarian follicles and granulosa cells, as indicated by Pgc7 and
inhibin-alpha expression, correlated with the absence of epithelial lesions. A reduction of Pten gene dosage, as in
Wv/Wv; Pten (+/−) mice, produced a similar, though less dramatic, phenotype. We conclude that deletion of Trp53
prolongs the survival of ovarian follicles in Wv mice and consequently prevents the proliferation of ovarian epithelial
cells and development of ovarian tubular adenomas. The results suggest that various cell types within the ovary
communicate andmutuallymodulate, and an intact tissue environment is required to ensure homeostasis of ovarian
surface epithelial cells. Especially, the current finding emphasizes the importance of ovarian follicles in suppressing
the hyperplastic growth of ovarian epithelial cells, dominating over the loss of p53.
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The white spotting (W) and variant (Wv) mice are spontaneous
mutants derived from selective breeding to follow their unique coat
color patterning, and several strains were identified to be caused by
mutations in the receptor tyrosine kinase c-Kit [1–3]. Inactivating
mutations of c-Kit affect most significantly the development of
melanocyte, mast cell, and germ cell lineages and have pleiotropic
effects on both embryonic development and hematopoiesis [4].
Homozygous W mutation in mice often leads to perinatal death
resulting from a severe anemia [4]. A unique variant, Wv, harbors a
c-Kit point mutation that reduces the c-Kit tyrosine kinase activity
to around 1%, and the developmental phenotypes are less severe
[2,3]. The heterozygous Wv mice in the C57BL/6 J(B6) background
have dorsal and/or ventral white spots, whereas the homozygous
mutant mice have a completely white fur coat [4,5]. The homozygous
mutant mice have about 1% to 5% of oocytes/follicles compared with
wild type at birth [1,6], and the follicles are depleted by about
2 months of age when the unaffected (wild type or heterozygous)
mice become reproductively mature. Depletion of germ cells/ovarian
follicles in females associates with elevation of gonadotropins
and development of epithelial lesions [5–7]. Both male and female
Wv/Wv mice are sterile but have a similar life span as wild type. The
homozygous Wv female mice present several physiological aspects of
menopause found in women [7,8].
In female mammals, the primordial germ cells are mitotically active
during embryogenesis but are stationary following meiosis to produce
primary oocytes immediately before birth [9]. Oocytes recruit and
become surrounded by granulosa cells to form follicles in late
embryogenesis for humans and the immediate neonatal period for
mice [9]. Thus, a finite population of oocytes is established at birth,
although this paradigm has been challenged and the controversy has
not yet been resolved [10–12]. Nevertheless, after birth, the majority
of the oocytes in mammals are progressively lost by atresia, and only a
fraction of the follicles in the ovarian reserve develop to maturity and
are used in ovulation [13,14]. The Tp53 family proteins play critical
roles in the development and attrition of ovarian follicles [15,16]. The
impact of Tp53 in female reproductive function has been recognized
in both mice and women, although the main mechanism is thought
to affect embryo implantation [17]. Several reports also noted the
influence of Trp53 on oocyte development and attrition [16,18].
Pten is another tumor suppressor gene known to affect oocyte
development and survival [19,20]. For most mammals in their natural
environment, the oocyte reserve and thus the reproductive lifetime
generally correlate with life span [21]. Women, especially in modern
times, are unique in that they experience an extended life span
following reproductive senescence due to ovarian follicle depletion, a
phenomenon known as menopause. In this aspect, the female Wv
mutant mice also have an extended life span following ovarian follicle
depletion and thus bear its biological consequences. The reduced
germ cell reserve and a normal life span of the mutant mice make the
Wv mice a suitable laboratory model of menopause [8].
The germ cell–deficient phenotype of the W series of mice was
characterized in the 1950s before the c-Kit mutation was identified in
the strains [1]. It was found that germ cells fail to survive and migrate
into the gonadal ridge during embryonic development [1]; for
females, the outcome is that few ovarian follicles are present in adults
[6]. Ovarian tumors arise following the depletion of germ cell/follicles
in the ovaries [5,6]. The tumors are classified as tubular adenoma, a
benign epithelial neoplasm [6]. A fraction of the ovaries developgranulosa cell tumors, which are likely promoted by the elevated
gonadotropins in the Wv/Wv mice following follicle depletion [6,7].
Although activating mutations or gene amplification of c-Kit
receptor tyrosine kinase have been found in some cancer types in
humans, c-Kit is not commonly expressed or involved in epithelial
ovarian cancer [22,23]. Rather, the formation of ovarian tubular
adenomas is attributed to the loss of function of c-Kit in the oocytes
and subsequent follicle depletion [5,6].
More recently, the ovarian tumor phenotype of the Wv mice was
studied to understand the relationship between reproductive
etiological factors such as menopausal biology and increased ovarian
cancer risk [5,24]. It was observed that the ovarian surface epithelia
proliferate and invaginate to form the tubular adenomas following
ovarian follicle depletion [5]. A reduction of cyclooxygenase (Cox)-2
gene dosage in the Wv/Wv mice leads to a reduced formation of the
tubular adenomas; however, complete Cox-2 knockout does not,
because of a compensatory expression of Cox-1 [5]. Suppression of
Cox-1 by either genetic knockout or pharmacologic inhibitors
prolongs postnatal ovarian follicle life span and also reduces the
development of ovarian tubular adenomas in the Wv mice [25].
The benign tubular adenomas in the Wv mice resemble, in
morphology, preneoplastic epithelial changes, such as surface
invaginations, inclusion cysts, and papillomatosis, found in aged
human ovaries [26,27]. These epithelial changes in ovaries precede
cancer development [28], and the increased ovarian epithelial
remodeling likely promotes the selection and expansion of cells
that have acquired oncogenic mutations such as the inactivation of
Trp53 or activation of Ras. The oncogenic mutation(s) confers
growth advantage, and ultimately the further expansion and selection
of the mutant cells lead to carcinomas. The ovarian tubular adenomas
in the ovary of the Wv mice resemble the low-grade ovarian cancer
tumors (type I, low–malignant potential tumors), which usually have
a wild-type Trp53 and KRas or Raf-1 activating mutation [29]. In
high-grade serous ovarian cancer, the tumor suppressor gene TP53 is
commonly mutated [29–32], which presumably allows the cell-
autonomous survival and growth of ovarian cancer cells.
In the current study, we tested if the addition of an oncogenic
mutation, such asTrp53 deletion or reduction of Pten gene dosage, may
convert the benign ovarian epithelial tumors into malignant cancer in
this epithelial ovarian tumor–bearing mouse model. The results of the
experiments were unexpected, and the findings provide further insight
to the etiology and mechanism of ovarian cancer, especially related to
cell-cell communication within the ovary and the increased ovarian
cancer risk found in peri- and postmenopausal women.
Materials and Methods
Sources, Genotyping, and Characteristics of Genetically
Modified Mice
All of the mouse strains used in the study have been kept in the
C57BL/6 J-background. Wv mouse (C57BL/6 J-KitW-v) breeding
pairs were originally obtained from Jackson Laboratory in 2002. The
Wv mouse colony has been maintained by inbreeding in our mouse
facility for the last 12 years. The Wv genotypes of the resulting
progeny were identified by coat color: white, gray with dorsal and/or
ventral spots, or black/agouti represents Wv/Wv homozygous
mutant, Wv/+ heterozygous mutant, or wild type, respectively.
The Trp53 (+/−) mice were purchased from Taconic (Hudson,
NY) [33,34]. Inactivation of the Trp53 gene in the mutant allele was
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neomycin-resistance gene (neo) cassette. The following primer sets
were used for polymerase chain reaction (PCR) genotyping that
amplifies the wild-type and targeted mutant Trp53 allele: 5′-
TGGTG CTTGG ACAAT GTGTT-3′; 5′-CTCCG TCATG
TGCTG TGACT-3′; 5′-GGATG ATCTG GACGA AGAGC-3′.
All three primers were used simultaneously in the PCR, yielding a
450–base pair wild-type and/or 650–base pair p53 mutant band.
A pair of Trp53 floxed (Trp53 [fl/fl]) mice was provided by Dr
Denise Connolly (Fox Chase Cancer Center, Philadelphia, PA). The
conditional mutant mice contain a functional Trp53 gene in which
exons 2 to 10 are flanked by loxP sites, and the breeding pair was
originally obtained from MMRRC (The Mutant Mouse Regional
Resource Center, www.mmrrc.org) [35,36]. The Pten (+/−) mice
were a gift from Dr Antony Di Cristofano and were bred and
genotyped following the published protocols [37]. The Pten allele was
inactivated by replacing exons 4 and 5 with a neo cassette [37]. All
animal studies were approved first by the Fox Chase Cancer Center
and then the University of Miami Institutional Animal Care and Use
Committee, and all experimental procedures were performed
following NIH guidelines.
Histology and Immunohistochemistry
Entire ovaries as well as the attached uterine horns from Wv
ovarian tumor models were dissected, fixed in 10% formalin, paraffin
embedded, and sectioned into 6 μm–thick slices collected on
positively charged glass slides. The sections were dewaxed in xylene
and hydrated through graded ethanol. Heat-induced antigen retrieval
was then carried out in 10-mM sodium citrate (pH 6.0) buffer in a
microwave initially set at high-power setting (#10) for 2 minutes,
followed by 10 minutes on low-power setting (#2). The endogenous
peroxidase activity was blocked by immersing the slides in 3% H2O2
in methanol for 15 minutes. After a 30-minute incubation in
blocking serum, slides were incubated with primary antibodies at 4°C
overnight at the following dilutions: rat monoclonal anti–Troma-1/
cytokeratin-8 (CK8) (Developmental Studies Hybridoma Bank from
The University of Iowa, line SP2/0) at 1:600 and mouse monoclonal
anti–inhibin-alpha (Serotec, clone 5070) at 1:200. Alternatively,
slides were blocked overnight at 4°C and incubated with goat
polyclonal anti-Pgc7 (R &D Systems, Cat#: AF2566) at 1:1000 for 1
to 2 hours at room temperature. After extensive washing, the slides
were incubated with horseradish peroxidase–labeled secondary
antibodies (BD Pharmingen) at 1:100 dilution for CK8 or anti-
rabbit labeled polymer horseradish peroxidase (Dako) for 35 minutes
at room temperature. Diaminobenzidine was used as the chromogen
for the immunoperoxidase reaction. The slides were counterstained
with hematoxylin and mounted in 50:50 xylene/Permount.
Preparation and Culturing of Mouse Primary Ovarian
Epithelial Cells
Primary cultures of mouse ovarian surface epithelial (MOSE) cells
were generated using a slightly modified protocol as described
previously [38,39]. Briefly, ovaries from 2- to 6-month-old female
mice were carefully dissected using sterilized surgical instruments.
These ovaries were then washed with PBS and incubated in 0.25%
Trypsin-EDTA solutions (Invitrogen) at 37°C for 1 hour. The surface
cells were washed off from the ovaries by repeated pipetting through a
1-ml pipette with the tip cut to fit the size of the ovaries, and then the
ovaries were removed and discarded. Dissociated MOSE cellssuspended in the medium were collected by a brief centrifugation
and cultured on six-well plates previously coated with 0.1% gelatin.
MOSE cells were maintained as monolayers in high-glucose DMEM/
F12 medium supplemented with 10% fetal bovine serum, 1 mM
glutamine, 10 ng/ml epidermal growth factor, 500 ng/ml hydrocor-
tisone, 5 μg/ml insulin, and 5 μg/ml transferrin. For Wv/Wv ovaries,
the epithelial tumor cells were isolated by incubation with DMEM/
F12 medium containing 0.5% collagenase (Invitrogen) for 2 hours at
37°C, and the isolated epithelial cells were cultured under the same
conditions as wild-type MOSE cells. By analysis of cytokeratin
expression using immunofluorescence microscopy, the cell prepara-
tions were verified to be more than 90% epithelial cells.
For gene deletion, primary cultures MOSE cells isolated from
Trp53 (f/f) or Wv/Wv; Trp53 (f/f) mice were treated with
replication-deficient adenovirus carrying Cre coding insert (adenovi-
ral Cre [Adv-Cre]) by addition of the viral vector (200 MOI) to the
cells. Adenovirus expressing LacZ was used as a control, and LacZ
expression indicated that high efficiency of infection (N90%) was
achieved at 200 MOI. The viral expression vectors were purchased
from the Vector Core at the University of Iowa and were used
according to the manufacturer’s protocol.
Cell Growth Assay
The growth rate of MOSE cells was analyzed using an MTT-like
WST-1 cell proliferation kit from Roche. Briefly, 2 × 104 MOSE cells
of various genotypes were seeded on 96-well plates previously coated
with 0.1% gelatin. These cells were allowed to grow for 24 to 96
hours. At each time point (24-hour intervals), the cell culture
medium was replaced with freshly prepared reaction buffer composed
of DMEM/F12 media containing 10% WST-1 solution. These cells
were then incubated for 1 hour at 37°C, and the accumulation of the
soluble formazan dye produced by viable cells was measured for
absorbance at 450 nm using a standard multiwell spectrophotometer.
The cell number correlates with the amount of soluble formazan dye.
Western Blot and Antibodies. Cultured MOSE cells were washed
with cold PBS and then lysed in SDS gel loading buffer. Lysates were
collected and denatured in boilingwater bath for 10minutes. The protein
extracts were separated on 8% or 10% SDS polyacrylamide gels,
transferred onto nitrocellulose membrane, and subjected to immuno-
blotting according to standard procedures. The primary antibodies used
were: anti–N-cadherin (mouse monoclonal, clone: 32/N-Cadherin, BD
Bioscience), anti–E-cadherin (mousemonoclonal, clone: 34/E-Cadherin,
BD Bioscience), anti–beta-catenin (mouse monoclonal, clone: 14/Beta-
Catenin, BD Bioscience), anti-COX1 (#160105, #160110, Cayman
Chemical), anti-COX2 (#160106, Cayman Chemical), anti–claudin-3
(Invitrogen), anti-PCNA (SC56, Santa Cruz), anti-p21 (mouse
monoclonal, clone: SXM30, BD Bioscience), anti–phospho-AKT
(#9276, Cell Signaling), anti-AKT (#9272, Cell Signaling), anti–
phospho-Erk1/2 (mouse monoclonal, clone: E10, Cell Signaling), anti-
Erk1/2 (#9102, Cell Signaling), and anti–beta-actin (clone AC-15,
Sigma). Chemoluminescence detection was performed using the Super-
Signal West Extended Duration Substrate detection kit (Pierce Biotech).Results
Development of Epithelial Lesions and Tubular Adenomas
from Surface and Rete Ovarri in the Ovary of Wv Mice
We have maintained a colony of Wv mice in C57BL/6 J
background by inbreeding for the last 12 years. Of the more than 300
Figure 1. Development of tubular adenomas in Wv/Wv mice. Ovarian morphology was compared between wild-type littermates (A and B)
and Wv/Wv (C to F) mice. CK8 (Troma-1) staining was used to highlight epithelial cells. (A, B) Two examples are shown of ovaries from
wild-type controls at 5 months of age. Arrows indicate a layer of CK8-positive surface epithelium. Arrowheads indicate the presence of
CK8-positive epithelial cells of rete ovarii in the hilus (A) or mesosalpinx (B) areas. (C) Representative examples of ovaries from Wv/Wv
mice at the age of 2 months and (D) 5 months. The slides shown are selected from section near the middle of the tissues. An arrow in
(C) indicates that the CK8-positive tubular adenoma lesion is contiguous with the ovarian surface epithelium. An arrow in (D) shows
peripheral lesions that are likely derived from the surface, and an arrowhead indicates distinct lesions that are likely derived from rete
ovarii, which are shown at a higher magnification in (E) and (F), respectively. A detailed time course of the development of the ovarian
tubular adenomas has been previously published [5].
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ovarian tubular adenomas, whereas none were observed in the wild-
type littermates.
The representative ovarian tumor morphology is shown in Figure 1.
At 5 months of age, the wild-type ovary displayed a complex structure
composed of various cell types. A single layer of Troma-1/CK8-
positive ovarian surface epithelial cells enclosed the ovarian cortex
containing follicles at all different stages of development (Figure 1, A
and B, arrow). In addition to the ovarian surface, CK8-positive
epithelia of rete ovarii were found in the hilus region (Figure 1A,
arrowhead) or the mesosalpinx areas (Figure 1B, arrowhead). In the
Wv/Wv ovary starting at around 2 months of age, the tissue was
replaced with tubular adenomas, shown as CK8-positive epithelial
layers mixed with stroma (Figure 1C). At this earlier stage, the
epithelial lesions were contiguous with the surface epithelium
(Figure 1C, arrow), suggesting that the infolding and invagination
of the surface epithelia gave rise to the benign tumor. The tubular
adenomas became enlarged for both epithelial and stromal
components and appeared more invasive (spreading into stromal
area) at later ages, as shown by an example from a 5-month-old Wv/
Wv female (Figure 1D).
Previously, we observed that, in cases of early ovarian lesions in
younger (7 to 10 weeks) Wv/Wv mice, the tubular structure is
contiguous with the monolayer of the surface epithelium, indicating
that the tubular epithelial lesions originate from the surface
epithelium [5]. Closer observation showed that the epithelial lesions
appeared to be of two different types (Figure 1D). The main tubularadenomas have flat epithelial layers and distribute throughout the
ovarian stroma (Figure 1, D and E, arrow). These lesions resemble
surface deep invaginations/papillomatosis and likely originate from
the surface epithelium. Another distinctive type of CK8-positive
lesion was found often around the stem or hilus ligament area
(Figure 1, D and F, arrowhead). The cells are columnar-to-stratified
epithelial in appearance and often locate deep within the tissues. This
second type of lesion likely is derived from rete ovarii because rete
ovarii structure and cysts are often observed in the area in the wild-
type or younger Wv/Wv ovaries.
Although dysplastic morphology is evident in some epithelial
components of the tubular adenomas, the ovarian epithelial tubular
structures in the Wv mice are considered nonmalignant tumors, and
the lesions are confined to ovarian tissues and do not become
metastatic. Histopathological evaluation also indicated their low-
grade cytological morphologies without evident mitotic figures.
The oviducts in Wv/Wv mice were not affected because we
consistently observed normal morphology of the ducts at all ages
despite the persistent presence of ovarian tubular adenomas in the
associated ovaries.
Suppression of Ovarian Tubular Adenomas in Wv Mice upon
Trp53 Deletion
We attempted to convert the benign ovarian tubular adenomas
into more neoplastic tumors by adding additional oncogenic
mutations into the Wv model. Because TP53 inactivation is common
in high-grade serous ovarian cancer, we first crossed and obtained
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tumor phenotypes.
Our experience in breeding Trp53 mutant mice was similar to that
reported [33]. We observed a reduction of the expected ratio of
Trp53 (−/−) pups from matings between parents of Trp53 (+/−)
genotype to approximately 55% of the expected number. Also, a sex-
biased ratio of 5:3 for male-to-female pups was observed. The
genotype distribution among progenies was also similar after crossing
into the Wv heterozygous background. Because Wv/Wv are sterile
and Trp53 (−/−) are poor breeders, we initiated breeding of Wv/+;
Trp53 (+/−) parents and kept any Wv/Wv; Trp53 (−/−) female
progenies for further analysis. In tabulating the breeding scheme over
a 6-year period, of about 1000 progenies genotyped, we only
identified 9 females and 14 males of Wv/Wv; Trp53 (−/−) genotype.
Thus, the Wv/Wv; Trp53 (−/−) genotypes exhibit an increased
embryonic lethality, with a 37% survival rate based on the expected
Mendelian ratio. The female Wv/Wv; Trp53 (−/−) mice needed
for analysis were even more difficult to generate +because of sex-
biased embryonic lethality, and only 29% of the expected number
was produced.
The ovaries from mice with the Trp53 (−/−) mutation alone were
not noticeably different in appearance and histology compared with
those of wild type, as reported previously [40]. We found that
crossing Wv mice into mutant p53 did not lead to the development of
large ovarian tumors or a malignant tumor phenotype. Instead,
surprisingly, the addition of the p53 mutation/deletion suppressed
the formation of tubular adenomas in the Wv/Wv mice. The mice
were analyzed before reaching 6 months of age because p53 null mice
often develop sarcomas and lymphomas after this age [34]. In the 18
ovaries collected from all 9 Wv/Wv; Trp53 (−/−) females at 2 to 6
months of age, we observed an intact ovarian structure without the
presence of tumor. Compared with wild-type ovaries that contained
follicles of a range of developmental stages (Figure 2A) or to Wv/WvFigure 2. Suppression of tubular adenomas inWv/Wv; Trp53 (−/−) ova
(B), andWv/Wv; Trp53 (−/−) (C, D) are shown. An immunostaining of
a 3-month-old Wv/Wv; Trp53 (−/−) mouse. A higher magnification o
from a section near the middle of the tissue. The staining shows a mo
Wv/Wv; Trp53 (−/−) ovary (C), and no tumor or epithelial lesions weovaries that were entirely permeated with tubular adenomas
(Figure 2B), the Wv/Wv; Trp53 (−/−) ovaries included no tumor
structure, exhibited a more homogeneous cortex, and contained
occasional follicles (Figure 2, C and D). Here, two examples with
distinctive morphologies are shown. The ovary in (Figure 2D) has a few
follicles yet contains corpora lutea–like structures.We speculate that the
ovary was harvested immediately following gonadotropin stimulation
and ovulation. Staining with CK8 shows that the representative ovary
has a smooth layer of epithelium on the surface of the ovaries and no
epithelium locates within the ovary (Figure 2, E and F).
Subtle Influence on Wv/Wv Ovarian Tumor Phenotypes with
Reduction of Pten Gene Dosage
We also undertook another cross to analyze ovaries from Wv/Wv;
Pten (+/−) mice with a goal to determine if a reduction of Pten tumor
suppressor gene might increase the malignant features of the tubular
adenomas in the Wv/Wv mice. Pten is often mutated or its expression
is lost in ovarian cancer, though most frequently in the endometrioid
subtype [41]. Homozygous Pten deletion causes early embryonic
lethality in mice; however, heterozygous Pten mutant mice are
predisposed to develop various epithelial tumors, most often the
endometrial type [37,42,43]. We produced and analyzed 10 Wv/Wv;
Pten (+/−) female mice at ages ranging from 3 to 12 months. The
addition of Pten mutation into Wv/Wv mice did not significantly
alter the tumor phenotype in most of the cases (Figure 3); rather, it
reduced the presence of epithelial tumor lesions in about one third of
the ovaries (6 out of 20 ovaries analyzed), especially at a younger age
(3 to 4 months). Four representative ovaries from the Wv/Wv; Pten
(+/−) mice are shown (Figure 3); two represent subtle changes
(Figure 3, A and B), and the other two represent a reduction in tumor
lesions (Figure 3, C and D). Upon close inspection, we observed the
presence of follicles in the Wv/Wv; Pten (+/−) ovaries that contain no
tubular epithelial lesions (Figure 3E). Consistently, the presence ofries. H&E staining of ovaries from 3-month-old wild type (A), Wv/Wv
the epithelial cell marker CK8 of the ovary in (C) is shown in (E) from
f the ovary in (E) is shown in (F). The images shown were selected
nolayer of CK8-positive epithelial cells enveloping a representative
re observed in the ovarian cortex.
Figure 3. Ovarian morphological features of Wv/Wv; Pten (+/−) mutant mice. Representative CK8 staining (of epithelial cells) of four
examples of ovaries from four 4-month-old Wv/Wv; Pten (+/−) mice is shown. Two ovaries (A, B) are similar to those of Wv/Wv mice, and
the other two ovaries shown (C, D) exhibit a reduced tumor lesion. An example of H&E staining of the ovary with reduced tumor lesion is
shown at higher magnification to visualize the presence of follicle structures (E).
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Wv/Wv; Pten (+/−) ovaries, and no follicle structures were ever
observed in areas containing tubular epithelial structures.
Thus, again in contrast to our expectation, a reduction of the Pten
gene dosage in the Wv mice only had subtle effects on the
development of tubular adenomas. Rather, reduced Pten prevented/
delayed the development of tubular adenomas in Wv/Wv mice,
although the effect was not as dramatic as in the case of Trp53
deletion because only 6 out of 20 ovaries showed a reduced epithelial
tubular adenoma lesions compared with 18 out of 18 ovaries from the
Wv/Wv; Trp53 (−/−) mice.
NO Increased Cell Proliferation in the Ovaries of Wv/Wv;
Trp53 (−/−) Mice
Suppression rather than promotion of tumor development by
Trp53 deletion or Pten gene dosage reduction was unexpected. Thus,
we examined by immunohistochemistry the effect of Trp53 deletion
on cell proliferation in the ovaries (Figure 4A).
We used Ki67 staining as an indication of cell proliferation.
Because Trp53 protein is difficult to be assayed in normal tissues
because of its low abundance, we used the cyclin inhibitor p21, a
Trp53-transcriptional target, as a reporter of Trp53 activity. In wild-
type ovaries, Ki67-positive cells were limited to a fraction of the
granulosa cells (Figure 4A, left panel, arrow), and most of the cell
populations, including surface epithelial and granulosa cells and
oocytes, were positive for nuclear p21 (Figure 4A, left panel). In the
Wv/Wv ovaries, Ki67-positive proliferating cells were abundant in
both epithelial and stromal compartments (Figure 4A, middle panel,
arrows). The tumor also contained widespread p21-positive cells,
which consisted about half of the cell population (Figure 4A, middle
panel). Interestingly, few cells in the Wv/Wv; Trp53 (−/−) ovary were
positive for Ki67, although the ovary had a much reduced p21staining, consistent with the loss of p53 activity (Figure 4A,
right panel).
The lack of cell proliferation did not apply to the endometrial
tissues of the Wv/Wv; Trp53 (−/−) mice (Figure 4B). The uterus of
the Wv/Wv; Trp53 (−/−) mice showed a similar extent of Ki67-
staining compared with those from wild-type or Wv/Wv mice
(Figure 4B, arrows). p21 staining of the endometrial epithelial cells of
Wv/Wv; Trp53 (−/−) was slightly reduced compared with those of
wild type or Wv/Wv, although the staining appeared largely
cytoplasmic. The stromal cells showed similar nuclear staining of
p21, suggesting that p21 expression in these cells was not regulated by
Trp53. Thus, we conclude that Trp53 deletion suppresses prolifer-
ation of all cell types in the Wv/Wv; Trp53 (−/−) ovaries but does not
significantly affect uterine cells in the same mice.
Increased Growth of Ovarian Surface Epithelial Cells in
Cultures upon Trp53 Deletion
Next, we examined if p53 deletion alters ovarian surface epithelial
cell survival and proliferation in culture to determine the possibility
that the effect of Trp53 deletion is non–cell autonomous.
We observed that newly isolated epithelial cells from Wv/Wv
ovaries had a greater growth rate than ovarian surface epithelial cells
isolated from wild-type controls at early passages (Figure 5A).
Nevertheless, the growth rate of the Wv/Wv epithelial cells was
reduced to the same level as that of the wild type at a later time, after
being maintained for four passages, or about 2 weeks, in culture
(Figure 5B). Western blot analysis indicated that, in early passages,
the cells had similar levels of N-cadherin, E-cadherin, and beta-
catenin, but the Wv/Wv epithelial cells had increased COX1, COX2,
and claudin-3 expression (Figure 5C). In these cases, the ovarian
surface epithelial cells from both the control (wild type) and Wv/Wv
mice were kept in a background of Trp53 (f/f). The addition of
Figure 4. Proliferation and p21 expression in ovarian and endometrial tissues. Ovaries (A) and associated uteri (B) were harvested from 3-
month-old wild-type (WT), Wv/Wv, andWv/Wv; Trp53 (−/−) mice and used for immunostaining with Ki67 as a proliferative index and with
p21 as a reporter of Trp53 activity. Adjacent sections were used for p21 and Ki67 stainings, and both the uterine horns and associated
ovaries were analyzed together on same slides. Representative images are shown. Arrows indicate examples of Ki67-positive cells.
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Wv mice or cells, but it allowed for Trp53 gene deletion upon
introducing the expression of Cre. Both Adv-LacZ and reverse
transcription PCR of Trp53 alleles indicated high efficiency of
infection and gene deletion in the cultured cells. Adv-Cre–mediated
Trp53 gene deletion enhanced the growth rates of both Wv/Wv
and wild-type ovarian epithelial cells (Figure 5, D and E). The
enhanced growth of ovarian surface epithelial cells in culture upon
Trp53 deletion has been previously reported [39,44]. The cells
were further analyzed by Western blot for cell cycle markers and
activation of signaling pathways (Figure 5F). Proliferating cell nuclear
antigen protein levels, an indicator of DNA replication and cell
proliferation, were consistent with results obtained from the WST-1
cell growth assay (Figure 5, A, B, D, E, and F). The loss of p21, a
Trp53 transcription target, indicated the complete inactivation of
Trp53 following the addition of Adv-Cre (Figure 5F). However,
Trp53 deletion did not significantly alter Akt or Erk1/2 activation, in
either wild-type or Wv/Wv cells, although the level of phospho-Erk1/
2 was slightly lower in Wv/Wv than the wild-type cells (Figure 5F).
Thus, Trp53 deletion itself does not impair or slow epithelial
proliferation in the Wv/Wv ovarian surface epithelial cells. The lack
of epithelial proliferation in the Wv/Wv; Trp53 (−/−) ovaries likely
was caused by a cell nonautonomous mechanism, such as growth
suppression imposed by stromal cells. We reason that epithelialproliferation was then restored in cultures, which were free of growth
suppression imposed by the ovarian stroma.
Prolonged Ovarian Follicle Life Span in Wv Mice with Trp53
Deletion
A clue to the mechanism underlying the unexpected finding that
addition of oncogenic mutation in Wv/Wv mice suppressed rather
than increased epithelial tumor development was the observation that
follicle structures were present in the tumor-free ovaries. Similar to
those of Wv/Wv; Pten (+/−), in the Wv/Wv; Trp53 (−/−) ovaries, a
number of follicle structures consisting of a circle of granulosa cells
surrounding an oocyte could be seen within the cortex (Figure 6).
Occasionally, mature follicles were also observed (such as in
Figure 2D). Immunostaining of PGC7, a germ cell and oocyte
antigen, confirmed the presence of ovarian follicles (Figure 6).
In the reproductively competent wild types of around 3 months of
age, the ovaries contained a large number (hundreds) of follicles at
various developmental stages, as revealed by PGC7 staining
(Figure 6A). Seen at a higher magnification, the primary follicles
were found located immediately underneath the surface epithelium
(Figure 6B). However, no ovarian follicles, at germ cell, primary, or
mature stage, were observed in the ovaries of Wv/Wv mice, which
were occupied by tubular adenomas (Figure 6C). In the Wv/Wv; p53
(−/−) ovaries, PGC7 staining confirmed that the structures indeed
Figure 5. Proliferation and signaling of primary mouse ovarian surface epithelial cells in cultures. Primary ovarian surface epithelial cells
were prepared from ovaries of mice of various genotypes. A total of six ovaries from three mice in each group were used to prepare the
epithelial cells of wild-type ovarian surface or Wv/Wv ovarian tubular adenomas. The cells were pooled for experiments. The growth rates
were measured by WST-1 assay (n = 3) from day 1 to 5. (A) Freshly prepared wild-type control (WT) and Wv/Wv ovarian epithelial cells
were compared. (B) Growth of WT and Wv/Wv ovarian epithelial cells was maintained in cultures for four passages or around 2 weeks.
The growth rate was then determined by WST-1 assay. (C) Lysates prepared from the cells were analyzed by Western blot for N-cadherin
(N-Cad), E-cadherin (E-Cad), beta-catenin (Beta-Cat), COX1, COX2, claudin-3, and beta-actin. (D, E) Ovarian surface epithelial cells were
prepared from p53 (f/f) and Wv/Wv; Trp53 (f/f) mice. The cells in primary cultures were treated with either Adv-Cre or Adv-LacZ (ctl), and
the growth rate was measured. (F) Lysates were prepared from the cells following treatment with Adv-Cre or Adv-LacZ and were analyzed
by Western blot. Three independent cell preparations per group were analyzed.
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at or near the largest cross section of an ovary (Figure 6D). Similar to
those of wild type, primary follicles appeared to align beneath theFigure 6. Rescue of germ cells/follicles in Wv/Wv; Trp53 (−/−) ovaries
ovaries of various genotypes to identify germ cells and follicles. (A) Th
month-old Wv/Wv. (D) Three-month-old Wv/Wv; Trp53 (−/−). (E) An
magnification to exemplify the follicle structures (arrow). (F) An exam
shown in higher magnification. Arrows indicate examples of primarysurface epithelium of the Wv/Wv; Trp53 (−/−) ovaries, as seen by
hematoxylin and eosin (H&E) (Figure 6E, arrows) or PGC7
(Figure 6F, arrows) staining shown at a high magnification. From. Immunostaining of the germ cell marker PGC7 was performed on
ree-month-old wild type and (B) at a higher magnification. (C) Three-
example of the Wv/Wv; Trp53 (−/−) ovaries is shown at a higher
ple of PGC7 immunostaining of the Wv/Wv; Trp53 (−/−) ovary is
follicles.
Figure 7. Inverse correlation between the presence of granulosa cells and epithelial lesions inWv/Wv ovaries. Representative examples of
tissue sections stained with the granulosa cell marker inhibin-alpha (A, C, E) and epithelial marker CK8 (B, D, F) in adjacent sections of
ovarian tissues from 3-month-old wild-type (A, B), Wv/Wv (C, D), andWv/Wv; Trp53 (−/−) (E, F) mice. An arrow indicates the single layer of
CK8-positive ovarian surface epithelial cells (B). To illustrate the inverse correlation between the presence of granulosa cells and epithelial
cells, arrowheads indicate that, in an area which is positive for inhibin-alpha (C), CK8 staining is absent in the adjacent section (D).
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Trp53 (−/−) ovaries had 12 +/− 5 PGC7-positive follicles compared
with 300 +/− 56 identified in a section of control ovaries. In contrast,
no ovarian follicles were detected in more than 200 Wv/Wv mice
analyzed, which is consistent with another recent study from our
laboratory reporting the time course of ovarian follicle depletion in
the mutant mice [25].
We also confirmed that the tumor-free Wv/Wv; Pten (+/−) ovaries
contained follicles (5 +/− 3 in a section), though to a lesser degree than
those of Wv/Wv; Trp53 (−/−). No follicles were observed in Wv/Wv;
Pten (+/−) ovaries that showed adenoma structures.
Thus, preservation of ovarian follicles may be responsible for a
reduced ovarian tumor phenotype in the Wv/Wv mice with Trp53
knockout or Pten heterozygous deletion. The finding supports the
hypothesis of follicle depletion as the cause of ovarian epithelial
proliferation and formation of tubular adenomas [24].
Inversed Correlation between Inhibin-alpha Expression and
the Presence of Epithelial Tubular Adenoma in the Wv Ovaries
We further analyzed the ovarian follicles by staining granulosa cells
for inhibin-alpha. In 3-month-old wild types, the ovaries contained
follicles at various stages throughout the cortex, and a number of large
and mature follicles were very prominent. These follicles contain
multiple layers of the inhibin-alpha–positive granulosa cells
(Figure 7A). Small primary follicles with only a single layer of
inhibin-alpha–positive granulosa cells located mostly at the outer
cortex, aligned along and immediately beneath the surface epithelium
(Figures 6B and 7A), which showed as a single-layered CK8-positive
cells (Figure 7B, arrow). In the follicle-depleted tubular adenomas of
Wv/Wv ovaries, inhibin-alpha–positive granulosa cells were greatlyreduced (Figure 7C). However, small patches of unorganized inhibin-
alpha–positive granulosa cells, which were remnants of degenerated
follicles, could be observed (Figure 7C, arrowheads). We recognized a
strict inverse correlation between the presence of inhibin-alpha–positive
granulosa cells and CK8-positive tubular adenomas at the same location
within an ovarian tubular adenoma (Figure 7, C and D, arrowheads).
The inverse correlation was confirmed in all 12 cases of Wv/Wv ovaries
analyzed for CK-8 and inhibin-alpha: where granulosa cells were
present, tubular adenomas were absent. The ovaries from Wv/Wv;
Trp53 (−/−) mice in which oocytes and follicles were preserved also
had an increased presence of granulosa cells (Figure 7E) and suppression
of epithelial tubular adenomas (Figure 7F).
Thus, the results suggest that ovarian epithelial cells and granulosa
cells are mutually exclusive.
Discussion
Although the p53 gene is the most prominent tumor suppressor, we
found in the specific situation of the ovarian tubular adenomas from
the Wv mice that deletion of Trp53 actually suppressed the tumor
phenotype. The germ cell–deficient Wv/Wv mice develop a benign
epithelial ovarian tumor, and the initial goal of our study was to
convert the benign tumors into malignant tumors by adding an
oncogenic mutation. Instead, we observed that deletion of Trp53
suppressed the ovarian tumor phenotype in the Wv/Wv mice.
Although initially perplexed by the results, we observed and realized
that the absence of p53 allows the prolonged survival of ovarian germ
cells and oocytes. Subsequently, the presence of follicles is critical in
maintaining the homeostasis of ovarian surface and rete ovarii
epithelia and is essential in preserving the structural arrangement of
the multiple cell types within an ovary (Figure 8).
Figure 8. Proposed mechanism for the suppression of epithelial proliferation by follicles in ovaries.A cartoon illustrates the interactions
between cell types within the ovary in maintaining tissue homeostasis. In the premenopausal stage, oocytes (ova) stimulate the
proliferation of granulosa cells and thematuration of the follicle structures, which suppress proliferation of both ovarian surface (OSE) and
rete ovarii epithelial cells. Based on the inverse correlation, we also speculate that granulosa cells from the remnants of degenerated
follicles can also suppress ovarian epithelial proliferation. The model suggests that, in the Wv/Wv ovaries, epithelial proliferation to form
tubular adenomas results from the depletion of ovarian follicles and associated granulosa cells and consequently the loss of growth
suppression imposed by a paracrine factor(s) produced by granulosa cells. Furthermore, Trp53 deletion rescues oocytes in the Wv/Wv
ovaries. Consequently, the oocytes stimulate granulosa cell growth, and the increased presence of granulosa cells suppresses epithelial
proliferation and the development of ovarian tubular adenomas.
98 Deletion of Trp53 Reverts Ovarian Tumor Phenotype Cai et al. Neoplasia Vol. 17, No. 1, 2015This finding suggests that Trp53 is critical in controlling the
survival and life span of ovarian germ cells and follicles in theWv mice
and that the depletion of follicles is a key causal factor for the ovarian
tubular tumor phenotype. Trp53 is known to regulate prenatal
oogenesis and oocyte attrition [16] and acts in chemical-induced
follicle loss [45]. Trp53 deletion in the Wv/Wv mice presumably
reduces oocyte apoptosis and prolongs follicle survival, and oocytes
then recruit and stimulate granulosa cells. Alternatively, Trp53 is also
directly important for controlling the growth and survival of
granulosa cells [46]. The impact of Trp53 activity on life span of
ovarian follicles observed in the current study adds to the recognized
roles of p53 and its family members in female reproduction
[15–17,47].
The tumor suppressor function of Trp53 is generally executed
through its cell autonomous regulation of gene expression of a large
collection of effectors in both cell growth arrest and programmed cell
death [48], and the tumor suppressor function and mechanisms have
been well demonstrated in mouse models [49]. In the current study,
as observed in culture, Trp53 deletion enhances proliferation of
ovarian surface epithelial cells, which is in agreement with previous
reports [36,44]. However, when globally absent in tissues, Trp53
deletion seems to suppress proliferation of ovarian epithelial cells and
reverts the tumor phenotype in the Wv mice. We attribute the
observation to a non–cell autonomous effect, that the presence of
ovarian follicles due to preservation following the loss of Trp53 in
oocytes then suppresses growth of the epithelial cells, despite the
simultaneous loss of Trp53 in the epithelial compartment. Indeed, in
a preliminary study, we also found that restricted Trp53 deletion in
the ovarian surface epithelial cells can greatly enhance tumor growth
in the Wv/Wv mice. These findings will be completed and reported
in a separate manuscript.Pten is known to have an active role in controlling ovarian oocyte
and follicle activation [19,20], which may explain our finding that a
reduction of Pten gene dosage also lessened ovarian follicle depletion
and tumor development in the Wv/Wv; Pten (+/−) mice. Pten
deletion in oocytes, or elimination of the downstream transcription
factor Foxo3a, also causes stage-specific follicular activation and
subsequent follicle depletion; however, no ovarian tubular adenomas
have been reported [19,20,50,51]. One possibility is that there are
residual follicles in the Foxo3a and conditional pten mutant mice
compared with the early and complete deletion in the Wv mice.
Additionally, another possibility is that residual granulosa cells may be
present following the degeneration of the large number of
prematurely activated follicles, and the granulosa cells prevent
epithelial proliferation to form tubular adenomas in the Foxo3a or
pten mutant mice.
The idea that an intact ovarian tissue structure is required for cell
homeostasis has been previously proposed [24,52]. One recognized
mechanism for the presence of ovarian follicles in suppressing ovarian
epithelial growth is the regulatory cycle of the ovarian-pituitary axis
[53]. Hormones, activin, and inhibin produced from oocyte-
associated granulosa cells suppress gonadotropins released from the
pituitary [53]. Upon follicle depletion, the increased gonadotropins
then stimulate epithelial proliferation, as proposed in the gonadotro-
pin stimulation hypothesis [54–58]. However, transgenic mice
overexpressing follicle-stimulating hormone and luteinizing hormone
do not develop ovarian epithelial tumors [59,60], and systemic
gonadotropin stimulation is not sufficient. The inverse relationship
between the inhibin-alpha–positive granulosa and the CK8-positive
epithelial cells in the same tissues, observed in the current study,
suggests that granulosa cells may be part of a negative paracrine signal
to suppress ovarian epithelial proliferation. A mutually exclusive
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previously in mouse ovarian tumors induced by SV40 T-antigen
(FvB/n-Tg(Amhr2-SV40TAg)1Bcv) [61]. Thus, the suppressive
activity of granulosa cells, within either intact follicles or clusters
from follicle remnants following oocyte degeneration, may be
common and may not be limited to tubular adenomas in the Wv/
Wv ovaries. Possibly, follicle depletion (and thus granulosa cell
degeneration) causes ovarian epithelial outgrowth by both increased
systemic gonadotropin stimulation and the loss of a local
suppressing signal from granulosa cells.
Another study also reported that additional deletion of Trp53
suppresses ovarian tumors in Pten-deficient and Kras mutant mice
[49]. The authors attributed their unusual finding as a new paradigm,
that wild-type Trp53 can promote survival and differentiation of the
Pten (−/−); Kras mutant tumor cells [49,62,63]. From the images
shown in the articles, it appears that Trp53 deletion also restored
ovarian follicles in the ovaries. However, the studies did not report or
discuss the analysis of ovarian follicle status or consider a non–cell
autonomous mechanism of Trp53 action.
Based on these observations and analyses, we propose a model for
the regulation of homeostasis of the ovarian cell types (Figure 8). It is
established that oocytes provide stimulatory signal for proliferation of
granulosa cells [9,64–66]. We propose that granulosa cells, either
associated with intact follicles or as remnants of degenerated follicles,
produce a paracrine factor that suppress proliferation of epithelial cells
either at the surface or in rete ovarii. The obvious possibility is that the
granulosa cell factor may be inhibin-alpha; however, inhibin-alpha
knockout does not stimulate epithelial proliferation in ovaries
[67,68]. Transforming growth factor–beta, an epithelial growth
suppressor, may be a good candidate, and identification of such factor
will be critical to verify the current model. The model suggests that, in
the Wv/Wv ovaries, depletion of ovarian follicles leads to the reduced
presence of granulosa cells and consequently the absence of the
paracrine factor to restrain the growth of both surface and rete ovarii
epithelia and the formation of tubular adenomas.
Our finding emphasizes the importance of ovarian follicles in
suppressing the hyperplastic growth and transformation of ovarian
epithelial cells, dominating over the cell autonomous activity due to
loss of Trp53. Perhaps, the follicle depletion hypothesis [24,69],
comprising both the incessant ovulation hypothesis [70,71] and the
gonadotropin stimulation theory [54–58], is most suitable to explain
the epidemiological observation that ovarian cancer risk is associated
with menopause (the depletion of ovarian follicle reserve) following
incessant ovulation and menopausal-increased gonadotropins when
the follicle reserve is depleted.
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